The term lipo-alkaloid is used for C 19 aconitane alkaloids containing one or two long-chain fatty acid residues. Lipo-alkaloids are transesterified derivatives of the most toxic and highly effective diester-type diterpene alkaloids, such as aconitine, hypaconitine, mesaconitine. Lipo-alkaloids are native minor compounds of aconite drugs, but their amount significantly increases after traditional processing, which is a general method in the Far Eastern traditional medicinal systems. Analytical works demonstrated that cautious processing (usually boiling) of crude aconite roots decreases the amount of normal diterpene alkaloids and increases the concentration of lipo-alkaloids resulting in the reduction of toxicity of the drugs. Many papers reported that lipo-alkaloids occur as a complex mixture in the drugs, and the isolation of the individual components is extremely difficult. These compounds have been identified using highly sensitive analytical methods (HPLC-MS, NMR), and semisynthetic approaches have been developed to ensure lipo-alkaloids in pure form for pharmacological studies. This review summarizes the structure, chemistry, semisynthesis, analytics and bioactivities of lipo-alkaloids. On the basis of 32 references this is the first comprehensive study on this topic, covering the data of 173 compounds.
Species belonging to the Aconitum genus are widely distributed throughout the Northern hemisphere. Based on empiric knowledge these plants are considered to be poisonous. Aconitum species accumulate highly toxic diterpene alkaloids, which have attracted considerable interest because of their complex structures, interesting chemistry and noteworthy physiological effects. These compounds can be divided into the major groups of C 20 , C 19 and C 18 diterpene alkaloids. Further, based on the number of ester groups present in the molecules, the main types are the diester diterpenoid alkaloids (DDAs), monoester diterpenoid alkaloids (MDAs), and triester diterpenoid alkaloids (TDAs). As concerns the latter group only a few papers were published recently, in which the detection of TDAs by highly sensitive analytical methods was reported, but the compounds were not isolated from the plants. The most toxic and highly effective diterpenoid alkaloids, such as aconitine (1) and its analogues, belong to the group of DDAs. Lipo-alkaloids (LAs) are in general analogues of these DDAs, therefore have attracted increasing attention in the last two decades.
The medicinal use of aconite drugs had disappeared from Western medicinal practices around the beginning of the 20 th century, in parallel with the recognition of the extremely narrow therapeutic range of diterpene alkaloids.
Nevertheless, in Far Eastern traditional medicinal systems (Traditional Chinese Medicine (TCM), Ayurveda, Kampo) aconite drugs have been applied for centuries as painkillers and antirheumatic agents [1] . The tubers and roots of aconites are used in the Eastern medicine only after cautious processing (usually boiling) to reduce their toxicity.
During the last few decades scientific research gained significant information on the chemistry, analytics, pharmacology and toxicology of native norditerpenoid alkaloids, present in unprocessed drugs. However, in spite of our rapidly growing knowledge concerning the chemistry of processed drugs there is still no sufficient information on their pharmacology and toxicology.
With the worldwide increasing spread of the oriental traditional medicinal systems, and with the increasing public interest towards phytomedicines, analytical studies on aconite drugs are of growing importance with respect to their safe application. Today the main research activities aimed the study of the effects of traditional processing methods on the chemical composition of aconite drugs, elaboration of adequate analytical methods for the quality control of these processing methods, and pharmacologicaltoxicological evaluations of LAs.
The aim of the present review is to survey the naturally occurring and semisynthetic LAs, their structures, biological activities, structure-activity relationships and synthesis. There has been no comprehensive study on this topic previously. Although a recently published review on diterpenoid alkaloids by Wang et al. [2] summarises the native C 20 , C 19 and C 18 diterpenoid alkaloids, LAs are referred in this paper only shortly. On the basis of 32 references 173 compounds are summarized in the present paper.
Aconite drugs -sources, processing methods, and traditional applications
Aconite drugs have been applied in Eastern traditional medicinal systems after thorough processing. Both crude and processed aconite drugs can be found in the national pharmacopoeias of several Asian countries. For example the current, 8 th edition of the Pharmacopoeia of the People's Republic of China (PhPRC) contains monographs of the crude and processed roots of A. kusnezoffii (Radix aconiti kusnezoffii, Caowu; Radix aconiti kusnezoffii praeparata, Zhicaowu), the crude and processed mother (Radix aconiti, Chuanwu; Radix aconiti praeparata, Zhichuanwu) and processed daughter roots (Radix aconiti lateralis praeparata, Fuzi) of A. carmichaelii [3] . A. carmichaelii is also the source of a herbal drug in the 7 th edition of the Korean Pharmacopoeia [4] . According to Hanuman et al. [5] A. ferox serves the same purpose within the Ayurvedic system. Considering the species used in TCM and the applied processing methods an extensive summary was given by Singhuber et al. [1] .
Although less attention is paid to the LA content of the listed drugs in the pharmacopoeial monographs and the official quantitative analytical methods focus on the determination of total or aconitine-type alkaloid content, several data are available in the literature on the LAs of crude and processed aconite roots (Table 1) . Moreover, according to our results and the study made by Wang et al., processing results in the increase of LA content in parallel with the decrease of DDA concentration [14, 15] , besides the formation of hydrolysed products. Nevertheless, less attention has been paid so far to the potential role of LAs in the pharmacological effects of processed aconite drugs. 
Lipo-alkaloids
2.1 Occurrence, chemistry, properties, semisynthetic approaches: The general term "lipo-alkaloid" was introduced by Kitagawa et al. [6] in 1982, when examining Aconiti tuber (Chuanwu) the authors isolated alkaloid mixtures containing long-chain fatty acid residues. The structure elucidation of the components was performed by several indirect methods of chemical degradation. The isolates (lipoaconitine, lipohypaconitine, lipomesaconitine, lipodeoxyaconitine) were treated with 1% NaOMe in MeOH at 18ºC for 6 h to obtain the respective 14benzoyloxy derivatives, methyl benzoate and mixtures of fatty acid methyl esters. The composition of the methyl esters were determined by GC-MS. The benzoyl substitution at C-14 was proved by solvolysis in dioxane-H 2 O (1:1) at 120ºC for 1 h, which yielded the respective 14-benzoyloxy derivatives. The connection of fatty acid residues at position C-8 was determined on the basis of MS fragmentation pathways and by 1 H and 13 C NMR analyses. The authors also produced semisynthetically the linoleoyl esters of aconitine (1), hypaconitine (55) and mesaconitine (76), in order to support their results and to provide 13 C NMR data of these compounds.
Many papers on the isolation of lipo-alkaloids from plant material [5, 7, 8, 9, 13] reported these compounds to be complex mixtures, and stated that direct chromatographic isolation of the individual components is extremely difficult because of their very similar physico-chemical properties and chromatographic behaviour. Therefore indirect degradation (methanolic [6] , alkaline [9, 13] ) methods were applied similarly to Kitagawa et al., and electrospray ionization mass spectrometry (ESI-MS) [7, 10, 11, 12, 17] , and matrix assisted laser desorption/ ionization mass spectrometry (MALDI-MS) [4, 8, 16] ) were used in order to elucidate the exact structures.
All lipo-alkaloids identified so far are based on the C 19 aconitane skeleton, on which the positions C-1, C-3, C-10, C-13, C-14, C-15 and the N atom can be substituted by different functional groups. The fatty acid residues primarily bond at C-8, but according to the recent report of Xu et al. [10] these residues can also connect in the position C-3, forming dilipo derivatives. [pyrodelphinine † ] 18 † compounds produced also semisynthetically Abbreviations: prp: propanoyl; laur: lauryl (dodecanoyl); myr: myristyl (tetradecanoyl); tten: tetradecenoyl; ttd: tetradecadienoyl; pdc: pentadecanoyl; pden: pentadecenoyl; pal: palmityl (hexadecanoyl); pme: palmitoleyl (hexadecenoyl); pmd: palmitadienoyl (hexadecadienoyl); hpdc: heptadecanoyl; hpden: heptadecenoyl; str: stearyl (octadecanoyl); ole: oleyl (octadecenoyl); lino: linoleyl (octadecadienoyl); -linolen: -linolenyl (octadecatrienoyl); -linolen: -linolenyl (octadecatrienoyl); linolen: linolenyl (octadecatrienoyl); ndc: nonadecanoyl; nden: nonadecenoyl; ndd: nonadecadienoyl; ecc: eicosanoyl; ecen: eicosenoyl; ecd: eicosadienoyl; ect: eicosatrienoyl; arch: arachidonyl (eicosatetrenoyl); ecp: eicosapentenoyl; hct: heneicosatetrenoyl; hcp: heneicosapentenoyl; dcc: docosanoyl; dch: docosahexenoyl; tcc: tricosenoyl; tcd: tricosadienoyl; ttc: tetracosanoyl; ttden: tetracosadecenoyl; pcc: pentacosanoyl group.
Aconitine (1), hypaconitine (55) and mesaconitine (76) were heated with an equimolar mixture of pyridine and linoleic acid to yield 14-benzoylaconine-8-O-linoleate (19), 14-benzoylhypaconine-8-O-linoleate (66) and 14benzoylmesaconine-8-O-linoleate (94), respectively. The authors also elaborated another reaction to obtain 14benzoylaconine-8-O-linoleate (19) with the heating of aconitine (1) in the mixtures of either collidine and linoleic acid, or of sodium linoleate in tetrahydrofuran. Bai et al. [18] found the pyridine containing method of Kitagawa et al. to give low yields of the desired products, so they made attempts to optimize the reaction conditions, and prepared seventeen LAs from aconitine (1), mesaconitine (76), pseudaconitine (123), delphinine (175), 1-acetyldelphisine (182), and falconerine (185), in a better yield. They concluded that the amount of pyridine in the reaction mixture is the key factor, since by increasing the concentration of pyridine, the yields of the products were decreased. As part of this work another, pyridine-free heating method was developed in which the reaction mixtures were heated in an oil bath (110ºC) under strong vacuum (0.1-0.6 mbar) for 3 hours. Using this process the average yield varied between 50-60%. The produced LAs  were 8, 14, 15, 18, 19, 25, and pyroaconitine (189) , which was identified as by-product. From the reaction of delphinine (175), the respective 176-181 esters, together with 191-193 as by-products, were isolated. Delphinine [17] . These compounds were used as reference materials to study the MS fragmentation pathways, and for the development of analytical methods. In our recent studies [14, 22] , we also applied the method of Bai et al. [18] for the production of 2, 3, 8, 12, 14, 15, 19, 23, 24 , 46, 50 from aconitine (1), in order to produce the compounds for pharmacological studies (Figure 1) . We also isolated pyroaconitine (189) as a regularly occurring by-product of this reaction. Minor changes (reduction of the temperature from 110ºC to 90ºC) to the original method were made, in case of highly unsaturated fatty acids (eicosapentenoic and docosahexenoic acids), because of their high heathsensitivity. 1 lipo-alkaloids 189 , 66; 529, 65, 135; 6, 7, 13, 14, 16, 18, 19, 22, 33, 34, 36, 38, 43, 59, 60, 65, 66, 67, 79, 78, 81, 85, 88, 90, 91, 93, 94, 96, 98, 97,  107, 110, 112, 114, 130 8, 15, 19, 60, 65, 66, 81, 90, 94, 130, 135, 136; 19, 53, 54, 60, 65, 66, 81, 90, 94, 120, 121, 122, 136, 135; 4, 5, 7, 8, 10, 12, 13, 17,  19, 21, 25, 47, 48, 49, 51, 52, 56, 57, 58, 59, 60, 61, 62, 63, 65, 64, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 77, 78, 80, 81, 83, 85, 86,  87, 88, 89, 90, 94, 96, 98, 100, 106, 112, 113, 117, 119, 129, 130, 131, 132, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144,  145, 146, 147, 149, 150; 6, 7, 10, 13, 15, 17, 19, 21, 25, 33, 37, 59, 60, 62, 65, 66, 67, 79, 80, 81, 83, 85, 87, 90, 92, 94, 96, 98, 107,  110, 117, 118, 130, 135, 138; 8, 9, 10, 11, 15, 16, 17, 18, 19, 20, 22, 21, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 39, 43, 44, 45,  60, 65, 66, 81, 82, 83, 84, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 113, 114, 116, 130 15, 19, 21, 25, 60, 65, 66, 67, 69, 79, 80, 81, 85, 89, 90, 92, 94, 96, 98, 100, 106, 110, 113, 117, 130, 136,  14 As part of the study of the traditional Chinese drug processing methods of aconite roots, Wang et al. [15] proved that during the decoction of the roots the artificial production of LAs takes place. This was demonstrated by adding palmitic acid to the decocted aconite root, which was found to be containing 14-benzoylaconine-8-Opalmitate (8), 14-benzoylhypaconine-8-O-palmitate (60), and 14-benzoyldeoxyaconine-8-O-palmitate (130) in amounts which were not present in the alkaloid mixture previously in the processed drugs. This experiment served as direct evidence for the previous speculations that LAs can be formed by transesterification reactions during preparation of the crude drugs.
Analytical studies:
With the development of highly sensitive analytical methods the number of identified LAs was exponentially increased. The main aspects of these developments were the increase of the sensitivity of the methods and the simplification of the sample preparation process. Highly sensitive matrix assisted laser desorption/ionization (MALDI) or electrospray ionization (ESI) mass spectrometry coupled high pressure liquid chromatographic methods (HPLC) were used most frequently for analysis and unambiguous identification of LAs (Table 3 ).
In the course of HPLC-MS analyses of aconite roots, lipoalkaloids can be identified by determining their quasimolecular peaks [M+H] + and analyzing their fragmentation. The [M+H] + signals of these compounds are in the range of 790-1200 m/z. Fatty acids are relatively easily eliminated by electrospray or chemical ionization from C-8, therefore the major fragment ion in the MS 2 spectra of these alkaloids is [M+H-RCOOH] + . Except for this point, the other fragmentation patterns in their MS n spectra are similar to those for aconitine-type DDAs. The neutral loss denotes the fatty acid, the major fragment ion determines the diterpene core of the molecule. The MS 2 spectrum of each LA is dominated by the product ion formed by elimination of the fatty acid. In MS 2 (except dilipo-alkaloids), LAs give rise to an [M+H-RCOOH] + ion at m/z 556 for lipohypaconitines, at m/z 570 for lipodeoxyaconitines, at m/z 572 for lipomesaconitines, at m/z 586 for lipoaconitines, at m/z 588 for lipo-10-hydroxymesaconitines, at m/z 600 for lipoyunaconitines, at m/z 602 for lipo-10-hydroxy-aconitines, at m/z 614 for lipo-3-acetyl-mesaconitines, at m/z 628 for lipo-3-acetyl-aconitines, at m/z 630 for lipo-3-acetyl-10-hydroxymesaconitines, at m/z 644 for lipo-3-acetyl-10-hydroxyaconitines [2, 7, 9, 12, 15] . In the MS 2 spectra of dilipoalkaloids the most intense peaks are those of the daughter ions containing one fatty acid ester side chain [10] .
Although several studies have been published on the identification of LAs from crude and processed drugs, less attention has been paid to obtain information about the quantitative properties of these compounds. The qualification of drugs for human use posses an increasing demand for this kind of information.
Mass spectrometric data are not appropriate to obtain exact details about the positions of double bonds in the esterifying fatty acid side chains (determination of bonding isomers of e.g. linolenic acid). This aspect may have special significance since it could have major influence on the pharmacological effects of the compounds, as it can be observed in the case of certain n-3 and n-6 fatty acids [19] . The questions on stability of aconite alkaloids (DDAs, MAs, LAs, pyrolysates) deserve special attention from the point of view of therapeutic application. Yue et al. [20] examined the stability of DDAs in different solvents (dichloromethane, ether, methanol and distilled water) and pH buffers using an HPLC/ESI-MS method for the elucidation of the DDAs by-products. They concluded that the decomposition pathways of DDAs are quite different and their different stabilities depend on the substituents at the N atom and substituents at C-3. The pyrolytic products of DDAs, such as deacetoxy aconitine-type alkaloids were observed in all the above solvents, whereas 8-methoxy-14benzoyl aconitine-type alkaloids were obtained only in methanol. The decomposition pathways of DDAs in buffers are related to the substituent on the C-3 position. Aconine, as hydrolysate by-product was only found in the pH 10.0 buffer, and the other hydrolysates and pyrolysates of DDAs, such as benzoylaconine and deacetoxy aconitine were observed in aqueous solutions at all pH-s. The decomposition pathway of aconitine (1) and mesaconitine (76) are similar, but different from that of hypaconitine (55).
Pharmacology:
Chang et al [21] reported that the extract of Radix aconiti stimulates the secretion of IL-1β, TNF- and GM-CSF produced by human peripheral mononuclear cells. Although in this study only the extract was studied and no isolated components responsible for the effects were investigated, these results provided the first evidence for pharmacological effects explaining the traditional utilization of aconite drugs in inflammatory conditions.
A series of LAs prepared semisynthetically by our workgroup (2, 3, 8, 12, 14, 15, 19, 23, 24, 46, 50) was tested for COX-1, COX-2 and 5-LOX inhibition activities in vitro. The aim of this work was to gain information about the pharmacology of LAs and to conclude some structure-activity relationships concerning the nature of esterifying fatty acids [22] . In this review we report the preparation and anti-inflammatory activities of four further LAs, 39, 40, 41, 42 ( Table 4 ). The protocol of semisynthesis, the methods of chromatographic purification and the pharmacological methods are identical with those of published in ref. [22] . All chemical substances used for the reactions were purchased as highly purified reagents from Sigma-Aldrich Ltd., Hungary. Purity (catalogue number) of the compounds: eicosanoic acid (10930): ≥99%; 11Z-eicosenoic acid (E3635): 99%; 11Z,14Z-eicosadienoic acid (E3127): min. 98%; 8Z,11Z,14Z-eicosatrienoic acid (E4504) 99%.
In the COX-1 inhibition assay 14-benzoylaconine-8-Oeicosapentenoate (46) exhibited the highest activity with 54.5% inhibition at 50 M. Besides this compound, 14benzoylaconine-8-O-eicosanoate (39), 14-benzoylaconine-8-O-eicosa-11Z-enoate (40), 14-benzoylaconine-8-Oeicosa-11Z,14Z-dienoate (41), 14-benzoylaconine-8-Oeicosa-8Z,11Z,14Z-trienoate (42), and 14-benzoyl-aconine-8-O-docosahexenoate (50) showed moderate inhibitory activities, all other LAs (2, 3, 12, 14, 15, 23, 24) were inactive against the COX-1 enzyme independently to the unsaturation and the length of the fatty acid chain. In the COX-2 inhibition assay, also 14-benzoylaconine-8-Oeicosapentenoate (46) demonstrated remarkable activity (66.1% inhibition at 50 M), which was followed by the moderately effective 14-benzoylaconine 8-O-eicosa-11Z,14Z-dienoate (41) and 14-benzoylaconine-8-Odocosahexenoate (50). Compounds (12, 15, 23, 24 and 41) , which contain fatty acid side chains with 1-3 double bonds also showed low inhibitory activities [except 14benzoylaconine-8-O-eicosa-11Z-enoate (40), which contained a relatively long carbon side chain], while compounds with saturated acyl groups [14-benzoylaconine-8-O-palmitoleate (12), 14-benzoyl-aconine-8-Ostearate (14), 14-benzoylaconine-8-O-eicosanoate (39)] were inactive against COX-2 enzyme. Thus, in case of COX-2 activity, a correlation between the grade of unsaturation in the ester group and the enzyme inhibitory activity may be presumed. In the LTB 4 formation inhibitory assay all tested compounds showed activity to a certain extent. The highest activity was measured in case of 14-benzoylaconine-8-O-docosahexenoate (50); its inhibitory effect was 61.0% at 50 M concentration. All other LAs expressed significant, but lower potency in 5-LOX mediated formation of LTB 4 . Regarding the 5-LOX assay a weak correlation could be noted between the activity and the length of the fatty acid chain.
Among the above compounds, two LAs, 14-benzoylaconine-8-O-palmitate (8) and 14-benzoylaconine-8-Olinoleate (19) , were investigated for acute toxicity using male CFLP mice together with the parent alkaloid aconitine (1) . It was found that both LA components were less toxic than aconitine (1) with several orders of magnitude. In the experiment all animals receiving 10 mg/kg intravenous LAs survived, while even 0.3 mg/kg of aconitine (1) was proven to be lethal [14] .
Since diterpene alkaloids are known to have different cardiovascular activities, Desai et al. [23] conducted a study with semisynthetically produced falconerine-8-Ostearate (187) and falconerine-8-O-linolenate (188), besides further 12 semisynthetic derivatives. The authors investigated the hypotensive and bradycardic actions of these compounds at two doses (200 μg/kg, 400 μg/kg., iv.) using N-deacetyllappaconitine (NDAL) as reference compound by measuring the differences in heart rate and in blood pressure in male Sprague-Dawley rats. It was observed that both compounds had relatively strong activities by reaching, and especially at the dose of 400 μg/kg, surpassing the activities of NDAL. The authors concluded that the examined compounds produced at least Aconitum lipo-alkaloids Natural Product Communications Vol. 6 (4) 2011 535 10% fall in heart rate or a 20% decline in blood pressure at both doses. Interestingly, pyrodelphinine (193) was also tested within the same study, but it expressed NDALequivalent activity only at the dose of 200 μg/kg, and its activity fell far behind from the activity of NDAL at the dose of 400 μg/kg. Kawata et al. [24] investigated the conversion of aconitine (1) to lipoaconitines by the human intestinal bacterial flora. The converting activities of Bacteroides fragilis, Klebsiella pneumoniae and Clostridium butyricum were studied by co-incubation with aconitine (1), and LAs being esterified with anteiso-pentadeceoic, pentadecenoic, palmitic, palmitoleic, stearic and oleic acids were detected. The esterifying fatty acids were characteristic to the strains used, and the respective LAs were found even after coincubation of aconitine (1) with sterile bacterial cells or a precipitate of disrupted bacterial cells in a phosphate buffer. As part of this study, antinociceptive activities of 14-benzoylaconine-8-O-palmitate (8) and 14benzoylaconine-8-O-oleate (15) were also tested in mice using aconitine (1) as reference compound. Aconitine (1) exerted a significant nociceptive threshold increasing effect with nociceptive hypersensitivity at the dose of 1 mg/kg, but 14-benzoylaconine-8-O-oleate (15) exhibited this at 3 mg/kg, and it was found to be toxic. 14-Benzoylaconine-8-O-palmitate (8) was only active at the dose of 30 mg/kg, therefore the authors concluded that LAs are not playing an important role in the antinociceptive action of aconite roots.
In the course of our work, the hERG-inhibiting ability of isolated and semisynthetically prepared diterpene alkaloids (14-benzoylaconine-8-O-palmitate (8) and pyroaconitine (189)) were examined [25] together with aconitine (1) . In this study the hERG channel activity was measured by the automated whole-cell patch clamp technique using the QPatch-16 system. Aconitine (1) expressed the highest activity, after which the activity of 14-benzoylaconine-8-O-palmitate (8) was the second highest. The main pyrolytic by-product of traditional processing methods of aconite roots, pyroaconitine (189) also showed modest, but still significant inhibition. This study does not allow establishment of a correlation between the structure and hERG channel activity of the alkaloids, but clearly indicate that the cardiovascular safety profile of Aconitum drugs should be evaluated taking into account the possible effect of the diterpene alkaloids on hERG channels.
Due to the fact that aconitine (1), hypaconitine (55) and mesaconitine (76) are the most active and the most toxic DDAs, their pharmacology and mode of action have been exhaustively explored. All three compounds were detected and quantified in human body fluids (urine and blood/plasma samples) by different highly sensitive methods [26] [27] [28] [29] [30] [31] [32] , which studies emphasised the toxicological importance of DDAs. To the present there is no relevant data on the same characteristics of LAs.
Conclusions, perspective
LAs are characteristic compounds of both processed and unprocessed aconite drugs, and their amount significantly increases after the traditional processing of the drugs. Because the close structural similarities of compounds substituted with lipoid chains, these alkaloids have not been isolated to date in pure form from natural sources. Therefore semisynthetic approaches have been developed to ensure the availability of LAs for pharmacological studies. The fact that the long chain fatty acid residues can reduce the high toxicity of DDAs, while still retaining the otherwise desirable antinociceptive and anti-inflammatory activities is of great importance. The mentioned semisynthetic reactions are relatively easy to carry out using DDAs and fatty acids as synthons of natural origin. The spectra of regular and odd-numbered fatty acids occurring naturally and the diversity of DDAs provide a large number of compounds for structure-activity relationship studies.
Results demonstrating that LAs are not just by-products of a traditional drug processing method put further emphasis on analytical work, because without proper analytical mapping and quantitation neither the safety nor the efficacy of drugs of human use can be determined. It should be noted that currently no unambiguous pharmacological results are available studying concomitantly all the main alkaloid-type compounds of crude and processed aconite roots (DDAs, MAs, LAs and pyrolysates) in the same test system. Such work may be able to clearly distinguish the real roles of these compounds. This would be advantageous not just from the view point of drug evaluation, but also in the process of integration of traditionally applied aconite drugs into the field of well-established medicinal use.
